Utilization of bone densitometry for prediction and administration of bisphosphonates to prevent osteoporosis in patients with prostate cancer without bone metastases receiving antiandrogen therapy

BACKGROUND: Prostate cancer subjects with prostate-specific antigen (PSA) relapse who are treated with androgen deprivation therapy (ADT) are recommended to have baseline and serial bone densitometry and receive bisphosphonates. The purpose of this community population study was to assess the utiliz...

Descripción completa

Detalles Bibliográficos
Autores principales: Holt, Abby, Khan, Muhammad A, Gujja, Swetha, Govindarajan, Rangaswmy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284007/
https://www.ncbi.nlm.nih.gov/pubmed/25565887
http://dx.doi.org/10.2147/CMAR.S74116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284007/
https://www.ncbi.nlm.nih.gov/pubmed/25565887
http://dx.doi.org/10.2147/CMAR.S74116

Ejemplares similares